Neoangiogenesis in Association with Moyamoya Syndrome Shown by Estimation of Relative Recirculation based on Dynamic Contrast-Enhanced MR Images

References

1. ↵
   Adams WM, Laitt RD, Li KL, Jackson A, Sherrington CR, Talbot P. Demonstration of cerebral perfusion abnormalities in moyamoya disease using susceptibility perfusion- and diffusion-weighted MRI. Neuroradiology 1999;41:86–92

   CrossRefPubMed
2. ↵
   Tsuchiya K, Inaoka S, Mizutani Y, Hachiya J. Echo-planar perfusion MR of moyamoya disease. AJNR Am J Neuroradiol 1998;19:211–216

   Abstract
3. ↵
   Yamada I, Himeno Y, Nagaoka T, et al. Moyamoya disease: evaluation with diffusion-weighted and perfusion echo-planar MR imaging. Radiology 1999;212:340–347

   PubMed
4. ↵
   Calamante F, Gadian DG, Connelly A. Quantification of perfusion using bolus tracking magnetic resonance imaging in stroke: assumptions, limitations, and potential implications for clinical use Stroke 2002;33:1146–1151

   Abstract/FREE Full Text
5. ↵
   Chabbert V, Ranjeva JP, Sevely A, Boetto S, Berry I, Manelfe C. Diffusion- and magnetisation transfer-weighted MRI in childhood moya-moya. Neuroradiology 1998;40:267–271

   CrossRefPubMed
6. ↵
   Kassner A, Annesley DJ, Zhu XP, et al. Abnormalities of the contrast re-circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast-enhanced imaging: a possible marker of vascular tortuosity. J Magn Reson Imaging 2000;11:103–113

   CrossRefPubMed
7. Jackson A, Kassner A, Zhu XP, Li KL. Reproducibility of T2* blood volume and vascular tortuosity maps in cerebral gliomas. J Magn Reson Imaging 2001;14:510–516

   CrossRefPubMed
8. ↵
   Jackson A, Kassner A, Annesley-Williams D, Reid H, Zhu XP, Li KL. Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade. AJNR Am J Neuroradiol 2002;23:7–14

   Abstract/FREE Full Text
9. ↵
   Moonen C, Liu G, Van Gelderen P, Sobering G. A fast gradient-recalled MRI technique with increased sensitivity to dynamic susceptibility effects. Magn Reson Med 1992;26:184–189

   PubMed
10. ↵
    Zhu X, Hutchinson C, Hawnaur J, Cootes TF, Taylor CJ, Isherwood I. Magnetic resonance image synthesis using a flexible model. Br J Radiol 1994 .67:976–982

    Abstract/FREE Full Text
11. ↵
    Li K, Zhu X, Jackson A. Parametric mapping of scaled fitting error in dynamic susceptibility contrast enhanced MR perfusion imaging. Br J Radiol 2000;72:126–132
12. ↵
    Mugikura S, Takahashi S, Higano S, et al. The relationship between cerebral infarction and angiographic characteristics in childhood moyamoya disease. AJNR Am J Neuroradiol 1999;20:336–343

    Abstract/FREE Full Text
13. ↵
    Suzuki J, Takaku A. Cerebrovascular “moyamoya” disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288–299

    CrossRefPubMedWeb of Science
14. ↵
    Takeuchi K, Shimizu K. Hypogenesis of bilateral internal carotid arteries. No To Shikei 1957;9:37–43
15. ↵
    Numaguchi Y, Gonzalez CF, Davis PC, et al. Moyamoya disease in the United States. Clin Neurol Neurosurg 1997;99[suppl 2]:S26−S30
16. ↵
    Fukui M. Current state of study on moyamoya disease in Japan. Surg Neurol 1997;47:138–143

    CrossRefPubMedWeb of Science
17. ↵
    Cramer S, Robertson R, Dooling E, Scott R. Moyamoya and Down syndrome. Stroke 1996;27:2131–2135

    Abstract/FREE Full Text
18. ↵
    Nagahiro S, Mantani A, Yamada K, Ushio Y. Multiple cerebral arterial occlusions in a young patient with Sjögren’s syndrome: case report. Neurosurgery 1996;38:592–595

    CrossRefPubMedWeb of Science
19. ↵
    Yamamoto T, Koeda T. Moyamoya-like vascular changes 6 years after radiation therapy in a boy [in Japanese]. No To Hattatsu 1996 :28:525–527

    PubMed
20. ↵
    Yoshimoto T, Houkin K, Takahashi A, Abe H. Angiogenic factors in moyamoya disease. Stroke 1996;27:2160–2165

    Abstract/FREE Full Text
21. ↵
    Wang MY, Steinberg GK. Rapid and near-complete resolution of moyamoya vessels in a patient with moyamoya disease treated with superficial temporal artery-middle cerebral artery bypass. Pediatr Neurosurg 1996;24:145–150

    PubMed
22. ↵
    Maeda M, Tsuchida C. “Ivy sign” on fluid-attenuated inversion-recovery images in childhood moyamoya disease. AJNR Am J Neuroradiol 1999;20:1836–1838

    Abstract/FREE Full Text
23. ↵
    Kuroda S, Houkin K, Nunomura M, Abe H. Frontal lobe infarction due to hemodynamic change after surgical revascularization in moyamoya disease: two case reports. Neurol Med Chir (Tokyo) 2000;40:315–320

    CrossRef
24. ↵
    Uno M, Nakajima N, Nishi K, Shinno K, Nagahiro S. Hyperperfusion syndrome after extracranial-intracranial bypass in a patient with moyamoya disease: case report. Neurol Med Chir (Tokyo) 1998;38:420–424

    CrossRef
25. ↵
    Dauser RC, Tuite GF, McCluggage CW. Dural inversion procedure for moyamoya disease. J Neurosurg 1997;86:719–723

    PubMedWeb of Science
26. ↵
    Mizoi K, Kayama T, Yoshimoto T, Nagamine Y. Indirect revascularisation for moyamoya disease: is there a beneficial effect for adult patients. Surg Neurol 1996;45:541–548

    CrossRefPubMed
27. ↵
    Ahmed R, Ahsan H. Imaging of Moya Moya disease. J Pak Med Assoc 1997;47:181–185

    PubMed
28. ↵
    Yamada I, Suzuki S, Matsushima Y. Moyamoya disease: comparison of assessment with MR angiography and MR imaging versus conventional angiography. Radiology 1995;196:211–218

    PubMedWeb of Science
29. ↵
    Feole J, Ali A, Fordham E, Huckman M, Shenker D. Serial SPECT imaging in moyamoya disease using I-123 IMP: a method of noninvasive evaluation and follow-up. Clin Nucl Med 1993;18:43–45

    CrossRefPubMed
30. Ikezaki K, Matsushima T, Kuwabara Y, Suzuki SO, Nomura T, Fukui M. Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emission tomography study. J Neurosurg 1994;81:843–850

    CrossRefPubMedWeb of Science
31. ↵
    Miller JH, Khonsary A, Raffel C. The scintigraphic appearance of childhood moyamoya disease on cerebral perfusion imaging. Pediatr Radiol 1996;26:833–838

    PubMed
32. ↵
    Hoshi S, Ohnishi T, Jinnouchi S, et al. Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT. J Nucl Med 1994;35:44–50

    Abstract/FREE Full Text
33. ↵
    Kuroki M, Nagamachi S, Hoshi H, et al. Cerebral perfusion imaging evaluates pharmacologic treatment of unilateral moyamoya disease. J Nucl Med 1996;37:84–86

    Abstract/FREE Full Text
34. ↵
    Cha S. Relative recirculation: what does it mean. AJNR Am J Neuroradiol 2002;23:1–2

    FREE Full Text
35. ↵
    Osborne A. Neoplasms and mass effects. In: Diagnostic Cerebral Angiography. Philadelphia: Lippincott Williams & Wilkins;1999 :313–340